Crest Medical Limited, a prominent player in the medical supplies industry, is headquartered in Great Britain. Established in 1991, the company has built a strong reputation for providing high-quality medical products and services, primarily focusing on the healthcare and emergency sectors. With a diverse range of offerings, including first aid kits, medical consumables, and bespoke healthcare solutions, Crest Medical stands out for its commitment to innovation and quality. The company has achieved significant milestones, including expanding its operational reach across Europe and beyond, solidifying its position as a trusted supplier in the market. Crest Medical Limited is recognised for its dedication to customer satisfaction and compliance with industry standards, making it a preferred choice for healthcare professionals and organisations seeking reliable medical solutions.
How does Crest Medical Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Crest Medical Limited's score of 26 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Crest Medical Limited reported total carbon emissions of approximately 11,961,300 kg CO2e, with significant contributions from Scope 3 emissions, which accounted for about 11,838,500 kg CO2e. Scope 1 emissions were recorded at 97,200 kg CO2e, while Scope 2 emissions totalled 35,600 kg CO2e. The company has made notable strides in its climate commitments, having achieved certification as a carbon neutral company for Scope 1 and 2 emissions in 2022. Crest Medical aims to reach net zero for these scopes by 2025. Looking ahead, the company has set a long-term target to achieve net zero across all scopes (1, 2, and 3) by 2040. This ambitious goal reflects their commitment to reducing their overall carbon footprint and aligns with industry standards for climate action. The emissions data for 2024 is cascaded from Crest Medical Ltd, which is a current subsidiary, and highlights the company's proactive approach to sustainability and environmental responsibility.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2024 | |
|---|---|---|
| Scope 1 | 73,370 | 00,000 |
| Scope 2 | 50,890 | 00,000 |
| Scope 3 | 27,640 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Crest Medical Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
